Top Markets
Coin of the day
Agile Therapeutics, Inc. Agile Therapeutics, Inc.

Agile Therapeutics, Inc.

AGRX
株式のランク #38231
Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated... Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated to the research, development, and market introduction of prescription contraception in the United States. Its flagship product is Twirla (also known by its development code, AG200-15), a combined hormonal contraceptive delivered through a patch applied once weekly. The company is also progressing with several pipeline innovations, including variations of Twirla and other new products: AG200-15 Extended Regimen (ER): A regimen designed to limit a woman to four withdrawal bleeding occurrences annually. AG200-15 smaller patch (SmP): This iteration aims for shorter, lighter withdrawal bleeds and potentially enhanced contraceptive efficacy. AG200-15 ER SmP: A combined regimen that allows for an extended contraceptive cycle while simultaneously providing fewer, lighter annual bleeding episodes. P-Patch: A contraceptive patch containing only progestin, specifically intended for women who cannot or choose not to use estrogen. Agile Therapeutics, Inc. was founded in 1997 and is based in Princeton, New Jersey.
株価
$1.51
最終同期: 2024-08-26
時価総額
$1.12M
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Agile Therapeutics, Inc. (AGRX)

カテゴリー

Agile Therapeutics, Inc.(AGRX)の発行済株式数
June 2024 時点の発行済株式数 6.86M
Agile Therapeutics, Inc. の最新の財務報告および株価によると、現在の発行済株式数は 6.86M です。December 2022 の終わりには、同社は 432.22K 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Agile Therapeutics, Inc.(AGRX)の発行済株式数の履歴(2012 ~ 2026)
各年末時点の発行済株式数
発行済株式数 変化
2026 (TTM) 6.86M 217.90%
2023 2.16M 398.99%
2022 432.22K 35,520.10%
2021 1.21K -97.13%
2020 42.34K 71.31%
2019 24.72K 44.06%
2018 17.16K 10.90%
2017 15.47K 9.44%
2016 14.14K 28.42%
2015 11.01K 93.22%
2014 5.70K 26.21%
2013 4.51K 0.00%
2012 4.51K 0.00%
類似企業や競合他社の発行済株式数